What is NCEL's P/E ratio?

NEWCELX LTD. (NCEL) currently trades at a P/E ratio of 4.11.

NEWCELX LTD. reports a Return on Equity (ROE) of 1.99%.

What is NCEL's dividend yield?

NEWCELX LTD. offers a dividend yield of 0.00%.

What is NCEL's Quality Score?

Our AI rates NCEL's overall financial quality at 54 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy NCEL?

Our AI Timing Score for NCEL is 55 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does NCEL belong to?

NEWCELX LTD. is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange

NCEL (NASDAQ) Stock Analysis | NEWCELX LTD.

Stock Check Daily update data at 8:30 AM
(Price: 2026-07-31 | FS: 2026-03-31)

NCEL AI Analysis Summary

Our AI summary for NCEL: NEWCELX LTD. (NASDAQ), Healthcare >> Biotechnology sector. The stock currently trades at a P/E of 4.11, ROE of 1.99%, a dividend yield of 0.00%. Its financial Quality Score stands at 54/100 — mid-range fundamentals relative to the market. The AI Timing Score is 55/100 — technical signals are mixed; watch for a clearer trend. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

NCEL

NEWCELX LTD.

US:NASDAQ STOCK Healthcare >> Biotechnology News 99

USD 3.49

0.13 (3.83%) Day Change

Watchlist Portfolio Compare Chart

4.11

P/E

0.05

D/E

2.0%

ROE

1.3%

ROA

0.00%

Div Yield

0.08

PEG

NEWCELX LTD.
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 3.49 Price 0.13 (3.83%) Day Change	NEWS SCORE: 99

NCEL, the overall quality is not quite good ( Quality = 54) and the timing to buy is ...(Sign In to See)...

Loading chart...

54 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: ROE is relatively low.
ROA is relatively low.
Acceleration of ROE growth rate is below our criteria.
Historical ROE is relatively low
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

In details, quality factors are not good , financial health is not quite good , and ability to make profit is not good , ...

Quality Factors

48%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	99
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	3.49
PBV / Sector	2.50 / 5.20
Earning Per Share	0.03

PE / Sector	4.11 / 19.97 GREAT
PEG or PE/Growth / Sector	0.08 / 1.22 GREAT
Average 1M Daily Value	0.11 M GREAT
Average 1W Daily Value	0.03 M GREAT

Timing Factors

42%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

50%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Ability to Make Profit

37%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	N/A / 98.71
NPM Average (%) / Sector	N/A / -1,721.76
NPM Change Average (%) / Sector	N/A / 5,211.62
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	1.26 / 27.02
ROA Average (%) / Sector	-199.39 / -368.17
ROA Change Average (%) / Sector	16.04 / 5,404.12 GOOD
ROE (%) / Sector	1.99 / 3.47
ROE Average (%) / Sector	-123.67 / 6.51
ROE Change Average (%) / Sector	-112.52 / 2,128.13
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Return to Investors

Dividend (%) / Sector	N/A / 0.04
Dividend Average (%) / Sector	N/A / 17.04
Dividend Change Average (%) / Sector	N/A / -1.75

Registration Details

Analyze Date	2026-08-01 08:00:13
Symbol	NCEL
Name	NEWCELX LTD.
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	5.38 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	18.10 / 9,903.94

News, Concensus, ...

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: Hohstrasse 1, Kloten, Switzerland, 8302

Phone: 41 44 512 21 50

Website: https://newcelx.com

Sector: Healthcare >> Biotechnology

Description: NewcelX Ltd., a biopharmaceutical company, engages in developing transformative stem-cell-derived therapies for Diabetes. The company develops NCEL-101, a cellular therapy product based on enriched pancreatic islet-like clusters for the treatment of Type 1 diabetes and Type 2 insulin dependent diabetes; AstroRx, an off-the-shelf cryopreserved cell therapy product for the treatment of Amyotrophic Lateral Sclerosis and neurodegenerative indications; and Dual Orexin-Receptor Agonist (DOXA), a small molecules platform for the treatment of sleep disorders, Neurodegenerative/ neuroinflammation diseases, and Diabetes Associated Neurological Disorders. It also develops iTOL-102, NCEL-201, NCEL-301, and NCEL-007. NewcelX Ltd. was founded in 2008 and is headquartered in Kloten, Switzerland.